1st May 2026: We added a new Tears of Themis code. Tears of Themis is a popular free-to-play visual novel from Genshin Impact makers HoYoverse. Blending dating sim and detective games, it mashes up ...

Mumbai: Gujarat Themis Biosyn is making a decisive global push, betting on a high-value pharmaceutical portfolio to scale beyond its traditional base. The company has signed an agreement to acquire ...

Themis Medicare Limited is a research-based pharmaceutical company, which is engaged in the manufacturing of pharmaceutical products, especially in formulation and active pharmaceutical ingredients ...

Gujarat Themis Biosyn Limited is an India-based company, which is principally engaged in the manufacturing of pharmaceuticals and medicinal chemical products. The Company is focused on the business of ...

The FEI 200kV Titan Themis Scanning Transmission Electron Microscope (STEM) is a scanning transmission electron microscope with several key capabilities. This microscope positions Michigan Tech ...

The National Numismatic Collection is comprised of approximately 1.6 million objects and is thought to be the largest collection of money and transactional objects in the world. Its diverse holdings ...

Seventy years ago, Lord Randolph Churchill delivered a stinging attack on the use of cloture to cut short debate in Britain’s Parliament. “The cloture is,” said he as quoted in a biography written by ...

Julia Kagan is a financial/consumer journalist and former senior editor, personal finance, of Investopedia. Thomas J. Brock is a CFA and CPA with more than 20 years of experience in various areas ...

For 3½ harrowing years, out of deference to an old ally, the U.S. has been playing along with the increasingly absurd legal fiction that revolt-torn Algeria is just another French province, like ...

The update builds on Themis V2, a life-sized humanoid introduced in April 2025 that the company described as one of the most agile robots in its class. Westwood Robotics has unveiled Themis Gen 2.5, a ...

Gujarat Themis Biosyn shares spiked 14.3 per cent in trade on BSE, logging an intra-day high at ₹369.4 per share. At 11:58 AM, Gujarat Themis Biosyn’s share price was trading 14.31 per cent higher at ...

Gujarat Themis Biosyn Ltd. will acquire a portfolio of anti-tuberculosis (TB) and anti-infective brands from Sanofi, the French-holding company of the Sanofi group. The company has entered into an ...